GlySure is a developer of in-hospital continuous blood glucose monitoring (CBGM) systems. Glucose levels can change unpredictably, and safe implementation of tight glycaemic control (TGC) requires rapid sampling of blood glucose levels to ensure the patient stays in the target range. GlySure’s team of scientists and engineers has created a CBGM system using a proprietary optical fluorescence sensor to meet the US$2 billion-plus worldwide demand for implementation of TGC in the hospital intensive care units.